Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Expert Opinion on Therapeutic Patents|May 7, 2013
Corticotropin-releasing factor 1 receptor antagonists: a patent reviewJohn P WilliamsThe American Journal of Managed Care|May 10, 2002
New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizationsJohn P Williams, Wayne LednarAmerican Journal of Therapeutics|April 14, 2022
Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201Jonathan S Jahr, John P WilliamsThe American Journal of Managed Care|January 9, 2003
Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costsJohn P Williams, Jonathan A MeyersAnnals of the New York Academy of Sciences|April 16, 2010
Calmodulin-an often-ignored signal in osteoclastsJohn P Williams, Keith Micoli, Jay M McDonaldBiochemistry|January 17, 2007
Molecular understanding of Abeta peptide interaction with isoflurane, propofol, and thiopental: NMR spectroscopic studyPravat K Mandal, John P Williams, Ratna MandalThe American Journal of Managed Care|June 17, 2008
The value of ambulatory care measures: a review of clinical and financial impact from an employer/payer perspectiveFrancois de Brantes, Paula S Wickland, John P WilliamsThe Cochrane Database of Systematic Reviews|January 14, 2017
Fibrin glue for pilonidal sinus diseaseJon Lund, Samson Tou, Brett Doleman, et al.Current Opinion in Nephrology and Hypertension|November 13, 2020
Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseasesNicholas M Selby, John P Williams, Bethan E PhillipsBiochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 20, 2005
Glucose is a key metabolic regulator of osteoclasts; glucose stimulated increases in ATP/ADP ratio and calmodulin kinase II activityKirsten I Larsen, Marina Falany, Wei Wang, et al.Pageof 16